“CO34 | Evaluation of emicizumab concentration and thrombin generation in a cohort of severe hemophilia A patients with and without inhibitor” (2025) Bleeding, Thrombosis and Vascular Biology, 4(s1). doi:10.4081/btvb.2025.241.